BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 15827123)

  • 1. Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme.
    Liang Y; Diehn M; Watson N; Bollen AW; Aldape KD; Nicholas MK; Lamborn KR; Berger MS; Botstein D; Brown PO; Israel MA
    Proc Natl Acad Sci U S A; 2005 Apr; 102(16):5814-9. PubMed ID: 15827123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma.
    Liang Y; Bollen AW; Aldape KD; Gupta N
    BMC Cancer; 2006 Apr; 6():97. PubMed ID: 16623952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A radial glia gene marker, fatty acid binding protein 7 (FABP7), is involved in proliferation and invasion of glioblastoma cells.
    De Rosa A; Pellegatta S; Rossi M; Tunici P; Magnoni L; Speranza MC; Malusa F; Miragliotta V; Mori E; Finocchiaro G; Bakker A
    PLoS One; 2012; 7(12):e52113. PubMed ID: 23284888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of alpha4 chain-containing laminins in human glial tumors identified by gene microarray analysis.
    Ljubimova JY; Lakhter AJ; Loksh A; Yong WH; Riedinger MS; Miner JH; Sorokin LM; Ljubimov AV; Black KL
    Cancer Res; 2001 Jul; 61(14):5601-10. PubMed ID: 11454714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteins and protein pattern differences between glioma cell lines and glioblastoma multiforme.
    Vogel TW; Zhuang Z; Li J; Okamoto H; Furuta M; Lee YS; Zeng W; Oldfield EH; Vortmeyer AO; Weil RJ
    Clin Cancer Res; 2005 May; 11(10):3624-32. PubMed ID: 15897557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression microarray analysis reveals YKL-40 to be a potential serum marker for malignant character in human glioma.
    Tanwar MK; Gilbert MR; Holland EC
    Cancer Res; 2002 Aug; 62(15):4364-8. PubMed ID: 12154041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of molecular subtypes of glioblastoma by gene expression profiling.
    Mischel PS; Shai R; Shi T; Horvath S; Lu KV; Choe G; Seligson D; Kremen TJ; Palotie A; Liau LM; Cloughesy TF; Nelson SF
    Oncogene; 2003 Apr; 22(15):2361-73. PubMed ID: 12700671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatty acid binding protein 7 as a marker of glioma stem cells.
    Morihiro Y; Yasumoto Y; Vaidyan LK; Sadahiro H; Uchida T; Inamura A; Sharifi K; Ideguchi M; Nomura S; Tokuda N; Kashiwabara S; Ishii A; Ikeda E; Owada Y; Suzuki M
    Pathol Int; 2013 Nov; 63(11):546-53. PubMed ID: 24274717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of histological markers for malignant glioma by genome-wide expression analysis: dynein, alpha-PIX and sorcin.
    Yokota T; Kouno J; Adachi K; Takahashi H; Teramoto A; Matsumoto K; Sugisaki Y; Onda M; Tsunoda T
    Acta Neuropathol; 2006 Jan; 111(1):29-38. PubMed ID: 16320026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk Score based on microRNA expression signature is independent prognostic classifier of glioblastoma patients.
    Sana J; Radova L; Lakomy R; Kren L; Fadrus P; Smrcka M; Besse A; Nekvindova J; Hermanova M; Jancalek R; Svoboda M; Hajduch M; Slampa P; Vyzula R; Slaby O
    Carcinogenesis; 2014 Dec; 35(12):2756-62. PubMed ID: 25322872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Active matrix metalloproteinase 9 expression is associated with primary glioblastoma subtype.
    Choe G; Park JK; Jouben-Steele L; Kremen TJ; Liau LM; Vinters HV; Cloughesy TF; Mischel PS
    Clin Cancer Res; 2002 Sep; 8(9):2894-901. PubMed ID: 12231534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression profile of glioblastoma multiforme invasive phenotype points to new therapeutic targets.
    Hoelzinger DB; Mariani L; Weis J; Woyke T; Berens TJ; McDonough WS; Sloan A; Coons SW; Berens ME
    Neoplasia; 2005 Jan; 7(1):7-16. PubMed ID: 15720813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of survival-related genes of the phosphatidylinositol 3'-kinase signaling pathway in glioblastoma multiforme.
    Ruano Y; Mollejo M; Camacho FI; Rodríguez de Lope A; Fiaño C; Ribalta T; Martínez P; Hernández-Moneo JL; Meléndez B
    Cancer; 2008 Apr; 112(7):1575-84. PubMed ID: 18260157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of novel candidate target genes in amplicons of Glioblastoma multiforme tumors detected by expression and CGH microarray profiling.
    Ruano Y; Mollejo M; Ribalta T; Fiaño C; Camacho FI; Gómez E; de Lope AR; Hernández-Moneo JL; Martínez P; Meléndez B
    Mol Cancer; 2006 Sep; 5():39. PubMed ID: 17002787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of p53 mutations in proliferating vascular cells in glioblastoma multiforme.
    Kawasoe T; Takeshima H; Yamashita S; Mizuguchi S; Fukushima T; Yokogami K; Yamasaki K
    J Neurosurg; 2015 Feb; 122(2):317-23. PubMed ID: 25415071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Determination of molecular glioblastoma subclasses on the basis of analysis of gene expression].
    Dmitrenko VV; Ershov AV; Stetsiuk PI; Likhovid AP; Laptin IuP; Shvarts DR; Mekler AA; Kavsan VM
    Tsitol Genet; 2014; 48(6):45-55. PubMed ID: 25536822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression profiling reveals Ki-67 associated proliferation signature in human glioblastoma.
    Jin Q; Zhang W; Qiu XG; Yan W; You G; Liu YW; Jiang T; Wang L
    Chin Med J (Engl); 2011 Sep; 124(17):2584-8. PubMed ID: 22040407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression-based molecular diagnostic system for malignant gliomas is superior to histological diagnosis.
    Shirahata M; Iwao-Koizumi K; Saito S; Ueno N; Oda M; Hashimoto N; Takahashi JA; Kato K
    Clin Cancer Res; 2007 Dec; 13(24):7341-56. PubMed ID: 18094416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of interleukin-13 receptor alpha2 in glioblastoma multiforme: implications for targeted therapies.
    Jarboe JS; Johnson KR; Choi Y; Lonser RR; Park JK
    Cancer Res; 2007 Sep; 67(17):7983-6. PubMed ID: 17804706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Established and emerging variants of glioblastoma multiforme: review of morphological and molecular features.
    Karsy M; Gelbman M; Shah P; Balumbu O; Moy F; Arslan E
    Folia Neuropathol; 2012; 50(4):301-21. PubMed ID: 23319187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.